Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
- PMID: 16510492
- PMCID: PMC1440609
- DOI: 10.1136/bmj.38766.624097.1F
Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study
Abstract
Objectives: To find out if the presence of the metabolic syndrome increases the risk of subsequent total and cardiovascular mortality, taking into account established risk factors for cardiovascular disease.
Design: Prospective cohort study.
Setting: General population.
Participants: A community based sample of 2322 men followed since 1970 for a maximum of 32.7 years, investigated at ages 50 and 70.
Main outcome measures: The relations of the metabolic syndrome defined by the national cholesterol education programme (NCEP) of the US National Heart, Lung, and Blood Institute or criteria of the World Health Organization (WHO) to subsequent total and cardiovascular mortality.
Results: When adding the metabolic syndrome to models with established risk factors for cardiovascular disease (smoking, diabetes, hypertension, and serum cholesterol) at age 50, presence of the metabolic syndrome as defined in the NCEP significantly predicted total and cardiovascular mortality (Cox proportional hazard ratios 1.36, 95% confidence interval 1.17 to 1.58; and 1.59, 1.29 to 1.95, respectively). The metabolic syndrome added prognostic information to that of the established risk factors for cardiovascular disease (likelihood ratio tests, P < 0.0001 for both outcomes). Similar results were obtained in a subsample without diabetes or manifest cardiovascular disease.
Conclusions: In a large, community based sample of middle aged men, the presence of the metabolic syndrome according to the definition of the NCEP gave long term prognostic information regarding total and cardiovascular mortality if the status of established risk factors for cardiovascular disease was known. If confirmed this may indicate clinical value in diagnosing the metabolic syndrome.
Figures




Comment in
-
Metabolic syndrome and mortality.BMJ. 2006 Apr 15;332(7546):882. doi: 10.1136/bmj.332.7546.882. BMJ. 2006. PMID: 16613961 Free PMC article. No abstract available.
-
Predictive value of metabolic syndrome is not clear.BMJ. 2006 Apr 29;332(7548):1036. doi: 10.1136/bmj.332.7548.1036-a. BMJ. 2006. PMID: 16644848 Free PMC article. No abstract available.
References
-
- Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-607. - PubMed
-
- Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28: 2289-304. - PubMed
-
- Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24: 683-9. - PubMed
-
- Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110: 1245-50. - PubMed
-
- Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National cholesterol education program versus World Health Organization metabolic syndrome in relation to allcause and cardiovascular mortality in the San Antonio heart study. Circulation 2004;110: 1251-7. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical